MHK
49
4
CPB
30
6
BAC
53
3
ADBE
49
3
MET
72
5
USB
55
-6
ADSK
70
2
FITB
63
3
BWA
48
2
GOOGL
40
-5
CL
58
2
DE
63
3
EL
25
4
STI
14
-17
M
37
12
CINF
53
2
MCHP
41
4
PBI
69
4
FLR
58
3
AMG
54
2
MHK
49
4
CPB
30
6
BAC
53
3
ADBE
49
3
MET
72
5
USB
55
-6
ADSK
70
2
FITB
63
3
BWA
48
2
GOOGL
40
-5
CL
58
2
DE
63
3
EL
25
4
STI
14
-17
M
37
12
CINF
53
2
MCHP
41
4
PBI
69
4
FLR
58
3
AMG
54
2
Financhill
Back

Protagonist Therapeutics Vs. Entrada Therapeutics Industry Stock Comparison

Sell
45

PTGX
Protagonist Therapeutics

Last Price:
46.45
Seasonality Move:
11.46%
Buy
65

TRDA
Entrada Therapeutics

Last Price:
18.85
Seasonality Move:
-34.62%
Sell
45
Protagonist Therapeutics (PTGX) is a Sell

Is Protagonist Therapeutics a Buy, Sell or Hold?

  • The current Protagonist Therapeutics [PTGX] share price is $46.46. The Score for PTGX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • PTGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
Entrada Therapeutics (TRDA) is a Buy

Is Entrada Therapeutics a Buy, Sell or Hold?

  • The current Entrada Therapeutics [TRDA] share price is $18.80. The Score for TRDA is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
  • TRDA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PTGX Stock Price Chart

What is Protagonist Therapeutics's stock price today?

  • The Protagonist Therapeutics share price today is $46.46
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing buying pressure, which is a positive indicator for future bullish movement.

TRDA Stock Price Chart

What is Entrada Therapeutics's stock price today?

  • The Entrada Therapeutics share price today is $18.80
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRDA is experiencing buying pressure, which is a positive indicator for future bullish movement.

PTGX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.01 Sell
Relative Strength Index (14 RSI): 57.05 Buy
Chaikin Money Flow: 782176 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.22 - 47.9) Buy
Bollinger Bands (100): (38.27 - 46.31) Buy

TRDA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.33 Buy
Relative Strength Index (14 RSI): 57.68 Buy
Chaikin Money Flow: 68474 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.1 - 19.1) Buy
Bollinger Bands (100): (15.08 - 17.94) Buy

PTGX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.58 Buy
20-day SMA: 44.66 Buy
50-day SMA: 45.25 Buy
200-day SMA: 35.78 Buy
8-day EMA: 42.72 Buy
20-day EMA: 43.78 Buy
50-day EMA: 44.02 Buy
200-day EMA: 36.88 Buy

TRDA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.36 Buy
20-day SMA: 18.36 Buy
50-day SMA: 17.01 Buy
200-day SMA: 15.21 Buy
8-day EMA: 18.37 Buy
20-day EMA: 18.21 Buy
50-day EMA: 17.42 Buy
200-day EMA: 15.87 Buy

Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.45 per share, and a decrease next year of $3.44 per share.

Entrada Therapeutics Earnings Growth & TRDA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.09 per share, and a decrease next year of $4.11 per share.

Protagonist Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Entrada Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):